# Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

> **NCT02001181** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 69 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** Tofacitinib ointment 20mg/g
- **DRUG:** Placebo ointment (Vehicle)

## Key facts

- **NCT ID:** NCT02001181
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2015-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001181, "Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02001181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*